首页> 外文期刊>PET clinics >Relevance of PET for pretherapeutic prediction of doses in peptide receptor radionuclide therapy
【24h】

Relevance of PET for pretherapeutic prediction of doses in peptide receptor radionuclide therapy

机译:PET与肽受体放射性核素治疗的剂量治疗前预测的相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Personalized dosimetry in radionuclide therapy has gained much attention in recent years. This attention has also an impact on peptide receptor radionuclide therapy (PRRT). This article reviews the PET-based imaging techniques that can be used for pretherapeutic prediction of doses in PRRT. More specifically the usage of 86Y, 90Y, 68Ga, and 44Sc are discussed: their characteristics for PET acquisition, the available peptides for labeling, the specifics of the imaging protocols, and the experiences gained from phantom and clinical studies. These techniques are evaluated with regard to their usefulness for dosimetry predictions in PRRT, and future perspectives are discussed.
机译:近年来,放射性核素治疗中的个性化剂量学已引起了广泛关注。这种关注也对肽受体放射性核素治疗(PRRT)产生了影响。本文介绍了可用于PRRT中治疗前剂量预测的基于PET的成像技术。更具体地说,讨论了86Y,90Y,68Ga和44Sc的用法:它们在PET采集中的特性,可用于标记的肽,成像方案的细节以及从体模和临床研究中获得的经验。评估了这些技术对PRRT中剂量学预测的有用性,并讨论了未来的观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号